financetom
Business
financetom
/
Business
/
Coinbase Global Insider Sold Shares Worth $3,776,150, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coinbase Global Insider Sold Shares Worth $3,776,150, According to a Recent SEC Filing
Dec 6, 2024 1:52 PM

04:17 PM EST, 12/06/2024 (MT Newswires) -- Frederick Ernest Ehrsam III, Director, on December 04, 2024, sold 11,421 shares in Coinbase Global ( COIN ) for $3,776,150. Following the Form 4 filing with the SEC, Ehrsam has control over a total of 10,417 shares of the company, with 10,417 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1679788/000167978824000216/xslF345X05/wk-form4_1733519567.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Binah Capital Shares Almost Double in Premarket Activity After Slumping 20% in Previous Regular Trading Session
--Binah Capital Shares Almost Double in Premarket Activity After Slumping 20% in Previous Regular Trading Session
Mar 28, 2024
05:50 AM EDT, 03/28/2024 (MT Newswires) -- Price: 19.16 , Change: +9.34, Percent Change: +98.32 ...
RH Stock Rises on Expectations for Full-Year Revenue Growth Amid Accelerating Demand Trends
RH Stock Rises on Expectations for Full-Year Revenue Growth Amid Accelerating Demand Trends
Mar 28, 2024
05:55 AM EDT, 03/28/2024 (MT Newswires) -- RH (RH) shares climbed early Thursday as the home furnishing retailer anticipates annual revenue growth in fiscal 2024 with demand trends to accelerate throughout the year, even though it recorded weaker-than-expected fourth-quarter results. The company forecast revenue to increase by 8% to 10% for the current fiscal year, as well as demand growth...
Hutchmed Says Supplemental New Drug Application for Savolitinib Accepted for Review in China
Hutchmed Says Supplemental New Drug Application for Savolitinib Accepted for Review in China
Mar 28, 2024
05:47 AM EDT, 03/28/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Wednesday the China National Medical Products Administration has accepted for review its supplemental new drug application for savolitinib as a treatment for adult patients with locally advanced or metastatic non-small cell lung cancer. If it is approved, the new label indication for savolitinib will be expanded to...
Veon Cancels Revolving Credit Facility After Full Repayment
Veon Cancels Revolving Credit Facility After Full Repayment
Mar 28, 2024
05:55 AM EDT, 03/28/2024 (MT Newswires) -- Veon ( VEON ) said Thursday it has repaid in full its outstanding balance of $805 million on its revolving credit facility and canceled the financing tool. The company said the repayment and cancellation will reduce its interest expenses. Price: 23.95, Change: +0.1, Percent Change: +0.42 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved